BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37953029)

  • 1. Transplantation for Hepatocellular Carcinoma.
    Hill A; Olumba F; Chapman W
    Surg Clin North Am; 2024 Feb; 104(1):103-111. PubMed ID: 37953029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
    Kutlu R; Karatoprak S
    J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
    Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA
    Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downstaging prior to liver transplantation for hepatocellular carcinoma: advisable but at the price of an increased risk of cancer recurrence - a retrospective study.
    Toso C; Meeberg G; Andres A; Shore C; Saunders C; Bigam DL; Shapiro AMJ; Compagnon P; Berney T; Majno P; Kneteman N
    Transpl Int; 2019 Feb; 32(2):163-172. PubMed ID: 30152891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
    Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
    Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?
    Dirican A; Karakas S
    J Gastrointest Cancer; 2020 Dec; 51(4):1148-1151. PubMed ID: 32839945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
    Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
    World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial.
    Mazzaferro V; Citterio D; Bhoori S; Bongini M; Miceli R; De Carlis L; Colledan M; Salizzoni M; Romagnoli R; Antonelli B; Vivarelli M; Tisone G; Rossi M; Gruttadauria S; Di Sandro S; De Carlis R; Lucà MG; De Giorgio M; Mirabella S; Belli L; Fagiuoli S; Martini S; Iavarone M; Svegliati Baroni G; Angelico M; Ginanni Corradini S; Volpes R; Mariani L; Regalia E; Flores M; Droz Dit Busset M; Sposito C
    Lancet Oncol; 2020 Jul; 21(7):947-956. PubMed ID: 32615109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
    Claasen MPAW; Sneiders D; Rakké YS; Adam R; Bhoori S; Cillo U; Fondevila C; Reig M; Sapisochin G; Tabrizian P; Toso C
    Transpl Int; 2023; 36():11648. PubMed ID: 37779513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
    Yao FY; Mehta N; Flemming J; Dodge J; Hameed B; Fix O; Hirose R; Fidelman N; Kerlan RK; Roberts JP
    Hepatology; 2015 Jun; 61(6):1968-77. PubMed ID: 25689978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.
    Welling TH; Eddinger K; Carrier K; Zhu D; Kleaveland T; Moore DE; Schaubel DE; Abt PL
    Liver Transpl; 2018 Sep; 24(9):1233-1242. PubMed ID: 29729113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatocellular carcinoma: an update.
    Zarrinpar A; Kaldas F; Busuttil RW
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):234-42. PubMed ID: 21669564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
    Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
    World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?
    Ersan V; Barut B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1152-1156. PubMed ID: 32856230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.